Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Vivian C. Aguilar, MD, is a Staff Physician in the Section of Urogynecology and Reconstructive Pelvic Surgery of the Department of Gynecology, as well as Director of the Fellowship for Female Pelvic Medicine and Reconstructive Pelvic Surgery at Cleveland Clinic Florida.
Before joining Cleveland Clinic in 2007, she worked at several other prominent hospitals and medical schools, including Drexel University College of Medicine in Philadelphia, New York University School of Medicine in New York, Robert Wood Johnson Medical Center in New Brunswick, N.J., and Saint Peter’s University Hospital, also in New Brunswick, where she was Director of Research in the Division of Female Pelvic Medicine and Reconstructive Surgery.
She is a Diplomate of both the American Board of Obstetrics and Gynecology and the National Board of Medical Examiners, and she is a Fellow of the American College of Obstetricians and Gynecologists. Her specialty interests include urogynecology, female pelvic medicine and reconstructive pelvic surgery.
Dr. Aguilar obtained her medical degree from the State University of New York School of Medicine Health Sciences Center at Stony Brook, N.Y. She then went on to complete a residency in obstetrics and gynecology at the University of Rochester’s Strong Memorial Hospital in New York and a fellowship in female pelvic medicine and reconstructive surgery at Brown University’s Women & Infants’ Hospital of Rhode Island. Dr. Aguilar is licensed to practice medicine in New York, Rhode Island, New Jersey and Florida.
She is active in research in her field, and she is principal or co-author of dozens of studies published in peer-reviewed journals or presented at leading medical meetings. She regularly gives presentations on topics in her field and has authored or co-authored several chapters of medical textbooks.
Among her many honors and awards include the Berlex Junior Faculty Development Award Workshop (2004), the Dean’s Teaching Excellence Award from the Clerkship in Obstetrics and Gynecology at Brown University School of Medicine (2002 and 2003), the Excellence in Teaching Award from the Women and Infants’ Hospital (2003) and the Senate Citation for Community Service from the State of Rhode Island and Providence Plantations (2002).
Dr. Aguilar is a member of the American Urogynecologic Society, American Association of Gynecologic Laparascopists, Association of Professors of Gynecology and Obstetrics, International Continence Society, National Association for Continence and the International Urogynecological Association.
pelvic reconstructive pelvic surgery, urogynecology
Fellowship in female pelvic medicine and reconstructive surgery, Brown University’s Women & Infants’ Hospital of Rhode Island
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/8/2012, Dr. Aguilar has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.